EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Electrochemiluminescence Drives Photodynamic Therapy In Vivo

Jia-Bao Lin, Ling-Ling Xu, Yong Liu, Hang Gao, Hong-Yuan Chen, Jing-Juan Xu iD

Advanced Science · 2026-03 · 13 (14)

DOI: 10.1002/advs.202512027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 22.12.2025. Verfasst von Jia-Bao Lin und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing, China. Hauptthemen laut MEDLINE: Photochemotherapy, Photosensitizing Agents, Luminescent Measurements, Electrochemical Techniques. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Excellent Research Program of Nanjing University, State Key Laboratory of Analytical Chemistry for Life Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Electrochemiluminescence (ECL) holds significant promise in the biomedical field, but remains a challenge for in vivo photodynamic therapy (PDT). Herein, a wearable light source of ECL to drive PDT (ECL‐PDT) is developed, in which a flexible ECL device (ECLD) is fabricated using an ECL gel containing Ru(bpy) 3 Cl 2 as the light‐emitting layer positioned between two transparent indium tin oxide‐coated substrates. By applying alternating current voltage, Ru(bpy) 3 + and Ru(bpy) 3 3+ are alternately generated within the ECLDs, and then collide to produce excited species, followed by high‐efficiency and stable ECL emission. The ECLDs can further activate photosensitizers to produce reactive oxygen species through a resonance energy transfer process, ultimately leading to oxidative damage of cancer cells. As a result, such ECLDs demonstrate excellent antitumor efficacy on cells, and tumor growth is distinctly inhibited in a tumor‐bearing mouse model. This work not only provides a convenient and effective ECL‐PDT strategy for cancer treatment, but also expands the application of ECLD as a wearable photonic healthcare device.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhotochemotherapyPhotosensitizing AgentsLuminescent MeasurementsElectrochemical TechniquesAnimalsMiceHumansCell Line, TumorReactive Oxygen SpeciesLuminescence

Stichwörter der Autor:innen

electrochemiluminescencein vivophotodynamic therapytumor suppression

Substanzen

Photosensitizing AgentsReactive Oxygen Species

Autor:innen und Institutionen

  • State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing, China.
  • School of Chemistry and Chemical Engineering, Yangzhou University, Yangzhou, China.

ORCID-Profile: Jing-Juan Xu

Förderung

  • National Natural Science Foundation of China
  • Excellent Research Program of Nanjing University
  • State Key Laboratory of Analytical Chemistry for Life Science

Zitieren

APA

Lin, J. B., Xu, L. L., Liu, Y., Gao, H., Chen, H. Y., & Xu, J. J. (2026). Electrochemiluminescence Drives Photodynamic Therapy In Vivo. Advanced Science, 13(14). https://doi.org/10.1002/advs.202512027

Vancouver

Lin JB, Xu LL, Liu Y, Gao H, Chen HY, Xu JJ. Electrochemiluminescence Drives Photodynamic Therapy In Vivo. Advanced Science. 2026;13(14). doi:10.1002/advs.202512027

BibTeX
@article{Lin2026,
  author = {Lin, Jia-Bao and Xu, Ling-Ling and Liu, Yong and Gao, Hang and Chen, Hong-Yuan and Xu, Jing-Juan},
  title = {Electrochemiluminescence Drives Photodynamic Therapy In Vivo},
  journal = {Advanced Science},
  year = {2026},
  volume = {13},
  number = {14},
  doi = {10.1002/advs.202512027}
}
Kostenlos starten →